Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118540893 | 11854089 | 3 | F | 2015 | 20160113 | 20151219 | 20160128 | EXP | JP-UCBSA-2015040247 | UCB | 73.00 | YR | M | Y | 0.00000 | 20160125 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118540893 | 11854089 | 1 | PS | XYZAL | LEVOCETIRIZINE DIHYDROCHLORIDE | 1 | Oral | 5 MG, ONCE DAILY (QD) | 325 | MG | 22064 | 5 | MG | FILM-COATED TABLET | QD | ||||
| 118540893 | 11854089 | 2 | SS | XYZAL | LEVOCETIRIZINE DIHYDROCHLORIDE | 1 | 325 | MG | 22064 | FILM-COATED TABLET | |||||||||
| 118540893 | 11854089 | 3 | SS | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | Oral | 120 MG, ONCE DAILY (QD) | 8640 | MG | U | 0 | 120 | MG | QD | ||||
| 118540893 | 11854089 | 4 | SS | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | 8640 | MG | U | 0 | |||||||||
| 118540893 | 11854089 | 5 | SS | POLARAMINE | DEXCHLORPHENIRAMINE MALEATE | 1 | Oral | 4 MG, ONCE DAILY (QD) | 76 | MG | U | 0 | 4 | MG | QD | ||||
| 118540893 | 11854089 | 6 | SS | POLARAMINE | DEXCHLORPHENIRAMINE MALEATE | 1 | 76 | MG | U | 0 | |||||||||
| 118540893 | 11854089 | 7 | C | Atorvastatin | ATORVASTATIN | 1 | UNK | U | 0 | ||||||||||
| 118540893 | 11854089 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | U | 0 | ||||||||||
| 118540893 | 11854089 | 9 | C | Omepral | OMEPRAZOLE | 1 | UNK | U | 0 | ||||||||||
| 118540893 | 11854089 | 10 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | UNK | U | 0 | ||||||||||
| 118540893 | 11854089 | 11 | C | Carbocisteine | CARBOCYSTEINE | 1 | UNK | U | 0 | ||||||||||
| 118540893 | 11854089 | 12 | C | Geninax | GARENOXACIN MESYLATE | 1 | UNK | U | 0 | ||||||||||
| 118540893 | 11854089 | 13 | C | Mucodyne | CARBOCYSTEINE | 1 | UNK | U | 0 | ||||||||||
| 118540893 | 11854089 | 14 | C | ASVERIN (TIPEPIDINE HIBENZATE) | TIPEPIDINE HIBENZATE | 1 | UNK | U | 0 | ||||||||||
| 118540893 | 11854089 | 15 | C | PL | ACETAMINOPHENCAFFEINEPROMETHAZINESALICYLAMIDE | 1 | UNK | U | 0 | ||||||||||
| 118540893 | 11854089 | 16 | C | AVAPRO | IRBESARTAN | 1 | UNK | U | 0 | ||||||||||
| 118540893 | 11854089 | 17 | C | CELESTAMINE | BETAMETHASONEDEXCHLORPHENIRAMINE MALEATE | 1 | 3 DF, UNK | U | 0 | 3 | DF | ||||||||
| 118540893 | 11854089 | 18 | C | CELESTAMINE | BETAMETHASONEDEXCHLORPHENIRAMINE MALEATE | 1 | 2 DF, UNK | U | 0 | 2 | DF | ||||||||
| 118540893 | 11854089 | 19 | C | CELESTAMINE | BETAMETHASONEDEXCHLORPHENIRAMINE MALEATE | 1 | 1 DF, UNK | U | 0 | 1 | DF | ||||||||
| 118540893 | 11854089 | 20 | C | Sulbacillin | AMPICILLIN SODIUMSULBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118540893 | 11854089 | 1 | Pruritus |
| 118540893 | 11854089 | 2 | Rash generalised |
| 118540893 | 11854089 | 3 | Pruritus |
| 118540893 | 11854089 | 4 | Rash generalised |
| 118540893 | 11854089 | 5 | Pruritus |
| 118540893 | 11854089 | 6 | Rash generalised |
| 118540893 | 11854089 | 7 | Product used for unknown indication |
| 118540893 | 11854089 | 8 | Product used for unknown indication |
| 118540893 | 11854089 | 9 | Product used for unknown indication |
| 118540893 | 11854089 | 10 | Product used for unknown indication |
| 118540893 | 11854089 | 11 | Product used for unknown indication |
| 118540893 | 11854089 | 12 | Product used for unknown indication |
| 118540893 | 11854089 | 13 | Product used for unknown indication |
| 118540893 | 11854089 | 14 | Product used for unknown indication |
| 118540893 | 11854089 | 15 | Product used for unknown indication |
| 118540893 | 11854089 | 16 | Product used for unknown indication |
| 118540893 | 11854089 | 17 | Rash |
| 118540893 | 11854089 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118540893 | 11854089 | HO |
| 118540893 | 11854089 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118540893 | 11854089 | Disseminated intravascular coagulation | |
| 118540893 | 11854089 | Eosinophil count increased | |
| 118540893 | 11854089 | Platelet count decreased | |
| 118540893 | 11854089 | Pneumonia | |
| 118540893 | 11854089 | Pyrexia | |
| 118540893 | 11854089 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118540893 | 11854089 | 1 | 20150525 | 20151105 | 0 | |
| 118540893 | 11854089 | 3 | 20150518 | 20151105 | 0 | |
| 118540893 | 11854089 | 5 | 20150710 | 20151105 | 0 | |
| 118540893 | 11854089 | 17 | 20150803 | 2015 | 0 | |
| 118540893 | 11854089 | 18 | 2015 | 2015 | 0 | |
| 118540893 | 11854089 | 19 | 20151006 | 0 | ||
| 118540893 | 11854089 | 20 | 2015 | 0 |